Telangana minister launches 5 projects at Genome Valley
Real Estate

Telangana minister launches 5 projects at Genome Valley

The five projects involve a cumulative investment of Rs 11 billion
Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs.

These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector.

Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so.

Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad.

See also:
Volcan Investments, not Vedanta, to invest in semi-conductor plant
MeitY Startup Hub, Meta collaborate to accelerate XR startups


The five projects involve a cumulative investment of Rs 11 billion Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs. These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector. Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so. Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad. See also: Volcan Investments, not Vedanta, to invest in semi-conductor plantMeitY Startup Hub, Meta collaborate to accelerate XR startups

Next Story
Infrastructure Energy

Avaada in Talks with Global Lenders to Raise $1 Bn Project Debt

Avaada Group is in discussions with global lenders including Standard Chartered Bank, Sumitomo Mitsui Banking Corporation (SMBC), BNP Paribas, and Societe Generale to raise over $ one billion (Rs 85.00 billion) in project finance debt to support its renewable energy expansion.The company currently has 3,000 MWp of solar and wind projects under construction and aims to reach 30 GWp capacity by 2030. It plans investments of Rs 35,000 to 400.00 billion in solar, wind, pumped storage projects (PSP), and green hydrogen and ammonia production.Chairman Vineet Mittal noted the firm’s active engageme..

Next Story
Infrastructure Energy

Tata Power Q4 Profit Rises 16.5% to Rs 10.43 Bn

Tata Power posted a net profit of Rs 10.43 billion in Q4FY25, up 16.5 per cent from Rs 8.95 billion in Q4FY24, beating analyst estimates of Rs 10.22 billion. Revenues rose 7.9 per cent to Rs 170.96 billion, in line with expectations.EBITDA increased 39.2 per cent to Rs 32.46 billion, driven by higher power sales, growth in solar rooftop projects, and a 73 per cent year-on-year rise in profit after tax in the distribution segment, mainly due to Odisha Discoms’ improved performance.For FY25, Tata Power achieved its highest ever annual revenue of Rs 645.02 billion. The company plans a capex of ..

Next Story
Infrastructure Transport

Major Ports Handle Record 855 MT Cargo in FY25

India’s 12 major ports handled a record 855 million tonnes (MT) of cargo in FY25, a 4.3 per cent increase over 819 MT in FY24, the Ministry of Ports, Shipping and Waterways announced.Growth was driven by container movement, up 10 per cent; fertilisers, up 13 per cent; petroleum, oil and lubricants (POL), up three per cent; and miscellaneous cargo, rising 31 per cent. Paradip Port Authority and Deendayal Port Authority crossed the 150 MT cargo mark for the first time. Jawaharlal Nehru Port Authority handled 7.3 million TEUs, a 13.5 per cent rise, setting a new record.POL cargo led with 254.5 ..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?